BioCryst Pharmaceuticals Inc
0.00
0.00
BioCryst Pharmaceuticals Inc
BioCryst Pharmaceuticals is a US commercial-stage biotech company that designs and develops medicines for rare and serious diseases like hereditary angioedema (HAE) and fibrodysplasia ossificans progressive (FOP). It was founded in 1986 and has headquarters in Durham, North Carolina, with additional offices in Dublin, Ireland and Birmingham, Alabama. BioCryst currently distributes two products used to treat the above illnesses, ORLADEYO and RAPIVAB, the latter of which has been approved by the US Food and Drug Administration (FDA). These products are also sold in China, Japan, Korea, and the UK. BioCryst stock is listed on the Nasdaq exchange and is a constituent of the Russell 2000 index. Start spread betting or trading CFDs on our BioCryst Pharmaceuticals share price.
Why 2 million+ traders and investors globally choose us¹
12,000 financial instruments- Tight spreads and no hidden fees
- Robust platform stability ²
- Ultra-fast execution ³
- 24/5 customer support
NaN
NaN
NaN%
NaN%
NaN%
NaN%
| 1 | NaN - NaN | 0% |
| Mon | Invalid Date - Invalid Date |
| Tue | Invalid Date - Invalid Date |
| Wed | Invalid Date - Invalid Date |
| Thu | Invalid Date - Invalid Date |
| Fri | Invalid Date - Invalid Date |
²
³